A Phase 3, Randomized Study of Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs Chemotherapy Alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer
收藏DataCite Commons2025-12-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012122/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease
提供机构：
Vivli
创建时间：
2025-12-10
